γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material-Reference-Cited by-同舟云学术

γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material

Published:2015-09 Issue:3 Volume:116 Page:473-479
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Menegakis Apostolos,von Neubeck Cläre,Yaromina Ala,Thames Howard,Hering Sandra,Hennenlotter Joerg,Scharpf Marcus,Noell Susan,Krause Mechthild,Zips Daniel,Baumann Michael

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Tumour growth and response to radiation;Zips,2009

2. Tumour and normal tissue response to radiotherapy;Hill,2013

3. Individualization of cancer treatment from radiotherapy perspective;Yaromina;Mol Oncol,2012

4. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription;Bentzen;Semin Radiat Oncol,2011

5. Clinical perspectives of cancer stem cell research in radiation oncology;Butof;Radiother Oncol,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired DNA Double-Strand Break Repair in Irradiated Sheep Lung Fibroblasts: Late Effects of Previous Irradiation of the Spinal Thecal Sac;Cancers;2024-08-26

2. Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma Spheroids;Cancers;2024-07-11

3. Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks;Radiotherapy and Oncology;2023-11

4. DNA as the main target in radiotherapy—a historical overview from first isolation to anti-tumour immune response;Strahlentherapie und Onkologie;2023-08-24

5. Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease;Molecular Oncology;2023-03-16